The Discounted Cash Flow (DCF) valuation of Silence Therapeutics PLC (SLN.L) is (10,286.63) GBP. With the latest stock price at 535.00 GBP, the upside of Silence Therapeutics PLC based on DCF is -2022.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.9% - 8.6% | 7.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (36,403.39) - (6,085.23) | (10,286.63) |
| Upside | -6904.4% - -1237.4% | -2022.7% |